Myelodysplastic Myeloproliferative Diseases
📧 Sign up to get email alerts when something new happens for Myelodysplastic Myeloproliferative Diseases.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-05EMA Authorised: Imatinib Teva (imatinib) — Teva B.V.
EMA authorised Imatinib Teva (imatinib) for multiple indications including chronic myeloid leukemia, precursor cell lymphoblastic leukemia-l…
-
EMA approval · 2025-05-06EMA Authorised: Imatinib Accord (imatinib) — Accord Healthcare S.L.U.
The EMA authorised Imatinib Accord (imatinib) for several indications, including Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dermatofibr…
-
EMA withdrawal · 2023-10-19EMA Withdrawn: Imatinib Koanaa (imatinib mesilate) — Koanaa Healthcare GmbH
The EMA status shows Imatinib Koanaa (imatinib mesilate) has been withdrawn from the market by Koanaa Healthcare GmbH.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders [Phase 2]
Phase 2 clinical trial update on donor peripheral stem cell transplantation for patients with advanced hematologic cancers and related disor…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating combination chemotherapy with donor stem cell transplant for aplastic anemia and hematologic cancers; compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder [Phase 2]
Phase 2 trial evaluating arsenic trioxide, ascorbic acid, dexamethasone, and thalidomide in chronic myeloproliferative disorders, leukemia, …
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [Phase 2]
A Phase 2 trial evaluating doxercalciferol in patients with myelodysplastic syndromes or related leukemias has completed.
-
EMA withdrawal · 2019-10-16EMA Withdrawn: Imatinib medac (imatinib) — Medac
The EMA has withdrawn Imatinib Medac (imatinib) from the market.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating total-body irradiation with fludarabine and peripheral stem cell transplantation in patients with hematologic cance…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) [Phase 3]
Phase 3 trial comparing peripheral blood stem cell transplant to bone marrow transplant in hematologic cancers completed.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia [Phase 2]
A Phase 2 trial evaluating peripheral stem cell transplant for high-risk leukemia has been terminated. The update provides the termination s…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a phase 1/2 study evaluating peripheral stem cell transplantation in patients with brea…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
This completed clinical trial evaluated caregiver support and its effect on the quality of life of patients receiving donor bone marrow tran…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bone marrow transplantation with cyclophosphamide and total-body irradiation in patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions [Phase 2]
Phase 2 pilot trial evaluating unrelated umbilical cord blood transplantation for leukemia and myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer [Phase 2]
This Phase 2 trial evaluates a conditioning regimen with fludarabine and busulfan followed by donor peripheral stem cell transplantation wit…
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 2]
A Phase 2 trial evaluating tacrolimus and mycophenolate mofetil to prevent acute graft-versus-host disease in patients with advanced hematol…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial evaluating azacitidine plus phenylbutyrate for acute myeloid leukemia or myelodysplastic syndromes has been completed…